Literature DB >> 8554080

Clinical features and associated systemic diseases of HLA-B27 uveitis.

M L Tay-Kearney1, B L Schwam, C Lowder, J P Dunn, D M Meisler, S Vitale, D A Jabs.   

Abstract

PURPOSE: To delineate the clinical features, course, complications, and associated systemic diseases in patients with HLA-B27-associated uveitis.
METHODS: We reviewed the records of 148 patients with HLA-B27-associated uveitis from two large uveitis practices.
RESULTS: There were 127 (86%) white and 21 (14%) nonwhite patients, and a male-to-female ratio of 1.5:1. The median age at onset of uveitis was 32 years; eight patients (5%) had their first attack after age 55 years. Acute anterior uveitis was noted in 129 patients (87%), and nonacute inflammation was noted in 19 (13%). Ocular involvement was categorized as unilateral or unilateral alternating in 138 patients (93%), but ten patients (7%) had bilateral, concurrent disease. The median duration of an attack was six weeks, and the median number of recurrences for patients with more than 12 months of follow-up was three. Cataracts were associated with posterior synechiae (P = .03), increased intraocular pressure (P = .003), and cystoid macular edema (P = .04). An HLA-B27-associated systemic disorder was present in 83 patients (58%), 30 of whom were women, and it was diagnosed in 43 of the 83 patients as a result of the ophthalmologic consultation. Thirty-four (30%) of 112 patients had a family history of a spondyloarthropathy.
CONCLUSIONS: Although HLA-B27-associated uveitis is usually described as a disease of young white men, women and nonwhites may also be affected. A subgroup of patients have severe disease and consequently more complications. Most patients have an associated systemic disease, including women, who appear to have more atypical spondyloarthropathies. The systemic diseases were frequently undiagnosed before the onset of the ocular disease and before the uveitis consultation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554080     DOI: 10.1016/s0002-9394(14)70533-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  32 in total

1.  Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.

Authors:  Allison R Loh; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

Review 2.  An update on the genetics of HLA B27-associated acute anterior uveitis.

Authors:  Tammy M Martin; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2011-04       Impact factor: 3.070

3.  Potential predictors for frequent relapse in human leukocyte antigen-B27-associated uveitis.

Authors:  Mirinae Kim; Yoon Seob Sim; Seung Yong Choi; Young-Hoon Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-29       Impact factor: 3.117

4.  pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.

Authors:  L K Gordon; M Eggena; G N Holland; J M Weisz; J Braun
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

Review 5.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

6.  HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis.

Authors:  K Pathanapitoon; S Suksomboon; P Kunavisarut; S Ausayakhun; S Wattananikorn; N Leetrakool; A Rothova
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

Review 7.  Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.

Authors:  Laura J Kopplin; George Mount; Eric B Suhler
Journal:  Ocul Immunol Inflamm       Date:  2016-05-27       Impact factor: 3.070

Review 8.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

9.  Gender differences in Iranian patients with ankylosing spondylitis.

Authors:  Abtin Shahlaee; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Elham Farhadi; Sasan Fallahi; Ahmad Reza Jamshidi
Journal:  Clin Rheumatol       Date:  2013-11-28       Impact factor: 2.980

10.  Clinical characteristics of patients with ankylosing spondylitis in India.

Authors:  Rohit Aggarwal; Anand N Malaviya
Journal:  Clin Rheumatol       Date:  2009-07-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.